Skip to main content
Erschienen in: Herz 8/2017

01.12.2016 | Original articles

Association between TLR2/TLR4 gene polymorphisms and COPD phenotype in a Greek cohort

verfasst von: A. Apostolou, T. Kerenidi, A. Michopoulos, K. I. Gourgoulianis, M. Noutsias, A. E. Germenis, M. Speletas

Erschienen in: Herz | Ausgabe 8/2017

Einloggen, um Zugang zu erhalten

Abstract

Background

Considering that the innate immune system plays a pivotal role in the pathogenesis of chronic obstructive pulmonary disease (COPD), we hypothesized that functional single-nucleotide polymorphisms (SNPs) of innate immune genes affect the disease phenotype and prognosis.

Aim

To elucidate the contribution of common functional TLR2 and TLR4 SNPs and genotypic deficiency of the mannose-binding lectin (MBL) protein, both as single parameters and in combination, in Greek COPD patients.

Results

In a cohort of 114 Greek COPD patients, we confirmed that the presence of TLR4-D299G or TLR4-T399I SNPs was significantly associated with an earlier COPD stage (p = 0.003 and p = 0.009, respectively). In comparison, the absence of any analyzed polymorphism, including those of TLR2-R753Q and genotypic MBL deficiency, was significantly associated with a more severe disease phenotype, characterized by more frequent exacerbations (p = 0.045).

Conclusion

Our findings support the notion that the presence of innate immune SNPs, such as functional polymorphisms of TLRs along with MBL deficiency, might exert a protective effect on the COPD phenotype, similar with other immune-mediated disorders.
Literatur
1.
Zurück zum Zitat Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757CrossRefPubMed Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ (2006) Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 367:1747–1757CrossRefPubMed
2.
Zurück zum Zitat Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, Lee JD, Tuder RM, Nicolls MR, Voelkel NF (2006) Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc Am Thorac Soc 3:687–690CrossRefPubMed Taraseviciene-Stewart L, Douglas IS, Nana-Sinkam PS, Lee JD, Tuder RM, Nicolls MR, Voelkel NF (2006) Is alveolar destruction and emphysema in chronic obstructive pulmonary disease an immune disease? Proc Am Thorac Soc 3:687–690CrossRefPubMed
3.
Zurück zum Zitat Sharma G, Hanania NA, Shim YM (2009) The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc 6:573–580CrossRefPubMed Sharma G, Hanania NA, Shim YM (2009) The aging immune system and its relationship to the development of chronic obstructive pulmonary disease. Proc Am Thorac Soc 6:573–580CrossRefPubMed
4.
Zurück zum Zitat Pauwels R, Rabe K (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620CrossRefPubMed Pauwels R, Rabe K (2004) Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet 364:613–620CrossRefPubMed
5.
Zurück zum Zitat Brusselle GG, Joos GF, Bracke KR (2011) New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378:1015–1026CrossRefPubMed Brusselle GG, Joos GF, Bracke KR (2011) New insights into the immunology of chronic obstructive pulmonary disease. Lancet 378:1015–1026CrossRefPubMed
6.
Zurück zum Zitat D’Hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, Brusselle GG (2005) Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? Respir Res 6:147CrossRefPubMedPubMedCentral D’Hulst AI, Maes T, Bracke KR, Demedts IK, Tournoy KG, Joos GF, Brusselle GG (2005) Cigarette smoke-induced pulmonary emphysema in scid-mice. Is the acquired immune system required? Respir Res 6:147CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Botelho FM, Gaschler GJ, Kianpour S et al (2010) Innate immune processes are sufficient for driving cigarette smoke-induced inflammation in mice. Am J Respir Cell Mol Biol 42:394–403CrossRefPubMed Botelho FM, Gaschler GJ, Kianpour S et al (2010) Innate immune processes are sufficient for driving cigarette smoke-induced inflammation in mice. Am J Respir Cell Mol Biol 42:394–403CrossRefPubMed
8.
Zurück zum Zitat Opitz B, van Laak V, Eitel J, Suttorp N (2010) Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 181:1294–1309CrossRefPubMed Opitz B, van Laak V, Eitel J, Suttorp N (2010) Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med 181:1294–1309CrossRefPubMed
9.
Zurück zum Zitat Sethi S, Maloney J, Grove L, Wrona C, Berenson CS (2006) Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:991–998CrossRefPubMedPubMedCentral Sethi S, Maloney J, Grove L, Wrona C, Berenson CS (2006) Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 173:991–998CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Hurst JR, Vestbo J, Anzueto A et al (2010) Susceptibilty to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363:1128–1138CrossRefPubMed Hurst JR, Vestbo J, Anzueto A et al (2010) Susceptibilty to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 363:1128–1138CrossRefPubMed
11.
Zurück zum Zitat Sinden NJ, Stockley RA (2010) Systemic inflammation and comorbidity in COPD: a result of “overspill” of inflammatory mediators from the lungs? Review of the evidence. Thorax 65:930–936CrossRefPubMed Sinden NJ, Stockley RA (2010) Systemic inflammation and comorbidity in COPD: a result of “overspill” of inflammatory mediators from the lungs? Review of the evidence. Thorax 65:930–936CrossRefPubMed
12.
Zurück zum Zitat Wouters EF, Reynaert NL, Dentener MA, Vernooy JH (2009) Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thorac Soc 6:638–647CrossRefPubMed Wouters EF, Reynaert NL, Dentener MA, Vernooy JH (2009) Systemic and local inflammation in asthma and chronic obstructive pulmonary disease: is there a connection? Proc Am Thorac Soc 6:638–647CrossRefPubMed
13.
14.
Zurück zum Zitat Johnson GB, Brunn GJ, Kodaira Y, Platt JL (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168:5233–5239CrossRefPubMed Johnson GB, Brunn GJ, Kodaira Y, Platt JL (2002) Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J Immunol 168:5233–5239CrossRefPubMed
15.
Zurück zum Zitat Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA, Brusselle GG (2006) Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 141:354–368CrossRefPubMed Maes T, Bracke KR, Vermaelen KY, Demedts IK, Joos GF, Pauwels RA, Brusselle GG (2006) Murine TLR4 is implicated in cigarette smoke-induced pulmonary inflammation. Int Arch Allergy Immunol 141:354–368CrossRefPubMed
17.
Zurück zum Zitat Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, Mira JB (2005) The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Iinfect Dis 41(Suppl 7):S408–S415CrossRef Texereau J, Chiche JD, Taylor W, Choukroun G, Comba B, Mira JB (2005) The importance of Toll-like receptor 2 polymorphisms in severe infections. Clin Iinfect Dis 41(Suppl 7):S408–S415CrossRef
18.
Zurück zum Zitat Pabst S, Yenice V, Lennarz M, Tuleta I, Nickenig G, Gillissen A, Grohe C (2009) Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in chronic obstructive pulmonary disease. Lung 187:173–178CrossRefPubMed Pabst S, Yenice V, Lennarz M, Tuleta I, Nickenig G, Gillissen A, Grohe C (2009) Toll-like receptor 2 gene polymorphisms Arg677Trp and Arg753Gln in chronic obstructive pulmonary disease. Lung 187:173–178CrossRefPubMed
19.
Zurück zum Zitat Speletas M, Merentiti V, Kostikas K, Liadaki K, Minas M, Gourgoulianis K, Germenis AE (2009) Association of TLR4-T399I polymorphism with chronic pulmonary disease in smokers. Clin Dev Immunol 2009:260286CrossRefPubMed Speletas M, Merentiti V, Kostikas K, Liadaki K, Minas M, Gourgoulianis K, Germenis AE (2009) Association of TLR4-T399I polymorphism with chronic pulmonary disease in smokers. Clin Dev Immunol 2009:260286CrossRefPubMed
20.
Zurück zum Zitat Ito M, Hanaoka M, Droma Y, Kobayashi N, Yasuo M, Kitaguchi Y, Horiuchi T, Ikegawa K, Katsuyama Y, Kubo K, Ota M (2012) The association of Toll-like receptor 4 gene polymorphisms with the development of emphysema in Japanese subjects: a case control study. BMC Res Notes 5:36CrossRefPubMedPubMedCentral Ito M, Hanaoka M, Droma Y, Kobayashi N, Yasuo M, Kitaguchi Y, Horiuchi T, Ikegawa K, Katsuyama Y, Kubo K, Ota M (2012) The association of Toll-like receptor 4 gene polymorphisms with the development of emphysema in Japanese subjects: a case control study. BMC Res Notes 5:36CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Rohde G, Klein W, Arinir U, Hagedorn M, Duerig N, Bauer TT, Gillissen A, Schultze-Werninghaus G, Epplen JT (2006) Association of the ASP299GLY TLR4 polymorphism with COPD. Resp Med 100:862–866CrossRef Rohde G, Klein W, Arinir U, Hagedorn M, Duerig N, Bauer TT, Gillissen A, Schultze-Werninghaus G, Epplen JT (2006) Association of the ASP299GLY TLR4 polymorphism with COPD. Resp Med 100:862–866CrossRef
22.
Zurück zum Zitat Budulac SE, Boezen HM, Hiemstra PS, Lapperre TS, Vonk JM, Timens W, Postma DS (2012) Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease. PLOS ONE 7:e43124CrossRefPubMedPubMedCentral Budulac SE, Boezen HM, Hiemstra PS, Lapperre TS, Vonk JM, Timens W, Postma DS (2012) Toll-like receptor (TLR2 and TLR4) polymorphisms and chronic obstructive pulmonary disease. PLOS ONE 7:e43124CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Sabroe I, Whyte MKB, Wilson AG, Dower SK, Hubbard R, Hall I (2004) Toll-like receptor (TLR) 4 polymorphisms and COPD. Thorax 59:81PubMedPubMedCentral Sabroe I, Whyte MKB, Wilson AG, Dower SK, Hubbard R, Hall I (2004) Toll-like receptor (TLR) 4 polymorphisms and COPD. Thorax 59:81PubMedPubMedCentral
24.
Zurück zum Zitat Turner MW (2003) The role of mannose-binding lectin in health and disease. Mol Immunol 40:423–429CrossRefPubMed Turner MW (2003) The role of mannose-binding lectin in health and disease. Mol Immunol 40:423–429CrossRefPubMed
25.
Zurück zum Zitat Koch A, Melbye M, Sørensen P, Homøe P, Madsen HO, Mølbak K, Hansen CH, Andersen LH, Hahn GW, Garred P (2001) Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285:1316–1321CrossRefPubMed Koch A, Melbye M, Sørensen P, Homøe P, Madsen HO, Mølbak K, Hansen CH, Andersen LH, Hahn GW, Garred P (2001) Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285:1316–1321CrossRefPubMed
26.
Zurück zum Zitat Speletas M, Gounaris A, Sevdali E, Kompoti M, Konstantinidi K, Sokou R, Tsitsami E, Germenis AE (2015) MBL2 genotypes and their associations with MBL levels and NICU morbidity in a cohort of Greek neonates. J Immunol Res 2015:478412CrossRefPubMedPubMedCentral Speletas M, Gounaris A, Sevdali E, Kompoti M, Konstantinidi K, Sokou R, Tsitsami E, Germenis AE (2015) MBL2 genotypes and their associations with MBL levels and NICU morbidity in a cohort of Greek neonates. J Immunol Res 2015:478412CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Neth OW, Bacher U, Das P, Zabelina T, Kabisch H, Kroeger N, Ayuk F, Lioznov M, Waschke O, Fehse B, Thiébaut R, Haston RM, Klein N, Zander AR (2010) Influence of mannose- binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors. Bone Marrow Transpl 45:13–19CrossRef Neth OW, Bacher U, Das P, Zabelina T, Kabisch H, Kroeger N, Ayuk F, Lioznov M, Waschke O, Fehse B, Thiébaut R, Haston RM, Klein N, Zander AR (2010) Influence of mannose- binding lectin genotypes and serostatus in allo-SCT: analysis of 131 recipients and donors. Bone Marrow Transpl 45:13–19CrossRef
28.
Zurück zum Zitat Lin CL, Siu LK, Lin JC, Liu CY, Chian CF, Lee CN, Chang FY (2011) Mannose-binding lectin gene polymorphism contributes to recurrence of infective exacerbation in patients with COPD. Chest 139:43–51CrossRefPubMed Lin CL, Siu LK, Lin JC, Liu CY, Chian CF, Lee CN, Chang FY (2011) Mannose-binding lectin gene polymorphism contributes to recurrence of infective exacerbation in patients with COPD. Chest 139:43–51CrossRefPubMed
29.
Zurück zum Zitat Mandal J, Malla B, Steffensen R, Costa L, Egli A, Trendelenburg M, Blasi F, Kostikas K, Welte T, Torres A, Louis R, Boersma W, Milenkovic B, Aerts J, Rohde GGU, Lacoma A, Rentsch K, Roth M, Tamm M, Stolz D (2015) Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study. Respir Res 16:150CrossRefPubMedPubMedCentral Mandal J, Malla B, Steffensen R, Costa L, Egli A, Trendelenburg M, Blasi F, Kostikas K, Welte T, Torres A, Louis R, Boersma W, Milenkovic B, Aerts J, Rohde GGU, Lacoma A, Rentsch K, Roth M, Tamm M, Stolz D (2015) Mannose-binding lectin protein and its association to clinical outcomes in COPD: a longitudinal study. Respir Res 16:150CrossRefPubMedPubMedCentral
30.
Zurück zum Zitat Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–65 Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–65
31.
Zurück zum Zitat American thoracic society (1998) Standardization of spirometry, 1994 update. Am J Resp Crit Care Med 152:1107–1136 American thoracic society (1998) Standardization of spirometry, 1994 update. Am J Resp Crit Care Med 152:1107–1136
32.
Zurück zum Zitat Stolz D, Boersma W, Blasi F, Louis R, Milenkovic B, Kostikas K et al (2014) Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Chest 146:328–338CrossRefPubMed Stolz D, Boersma W, Blasi F, Louis R, Milenkovic B, Kostikas K et al (2014) Exertional hypoxemia in stable COPD is common and predicted by circulating proadrenomedullin. Chest 146:328–338CrossRefPubMed
33.
Zurück zum Zitat Liadaki K, Petinaki E, Skoulakis C, Tsirevelou P, Klapsa D, Germenis AE, Speletas M (2011) Toll-like receptor 4 gene (TLR4), but not TLR2, polymorphisms modify the risk of tonsillar disease due to Streptococcus pyogenes and Haemophilus influenzae. Clin Vaccine Immunol 18:217–222CrossRefPubMed Liadaki K, Petinaki E, Skoulakis C, Tsirevelou P, Klapsa D, Germenis AE, Speletas M (2011) Toll-like receptor 4 gene (TLR4), but not TLR2, polymorphisms modify the risk of tonsillar disease due to Streptococcus pyogenes and Haemophilus influenzae. Clin Vaccine Immunol 18:217–222CrossRefPubMed
34.
Zurück zum Zitat Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–191CrossRefPubMed Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, Frees K, Watt JL, Schwartz DA (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25:187–191CrossRefPubMed
35.
Zurück zum Zitat Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF (2002) Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186:1522–1525CrossRefPubMed Agnese DM, Calvano JE, Hahm SJ, Coyle SM, Corbett SA, Calvano SE, Lowry SF (2002) Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J Infect Dis 186:1522–1525CrossRefPubMed
36.
Zurück zum Zitat Van der Graaf CA, Netea MG, Morré SA, Den Heijer M, Verweij PE, Van der Meer JW, Kullberg BJ (2006) Toll-like receptor 4 Asp299Gly/Thr399Ile poly- morphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 17:29–34PubMed Van der Graaf CA, Netea MG, Morré SA, Den Heijer M, Verweij PE, Van der Meer JW, Kullberg BJ (2006) Toll-like receptor 4 Asp299Gly/Thr399Ile poly- morphisms are a risk factor for Candida bloodstream infection. Eur Cytokine Netw 17:29–34PubMed
37.
Zurück zum Zitat Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, van der Meer JW, Netea MG (2008) Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14:346–352CrossRefPubMedPubMedCentral Ferwerda B, McCall MB, Verheijen K, Kullberg BJ, van der Ven AJ, van der Meer JW, Netea MG (2008) Functional consequences of toll-like receptor 4 polymorphisms. Mol Med 14:346–352CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Hawn TR, Scholes D, Li SS, Wang H, Yang Y, Roberts PL, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM (2009) Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLOS ONE 4:e5990CrossRefPubMedPubMedCentral Hawn TR, Scholes D, Li SS, Wang H, Yang Y, Roberts PL, Stapleton AE, Janer M, Aderem A, Stamm WE, Zhao LP, Hooton TM (2009) Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLOS ONE 4:e5990CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Yuan FF, Marks K, Wong M, Watson S, de Leon E, McIntyre PB, Sullivan JS (2008) Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 86:268–270CrossRefPubMed Yuan FF, Marks K, Wong M, Watson S, de Leon E, McIntyre PB, Sullivan JS (2008) Clinical relevance of TLR2, TLR4, CD14 and FcgammaRIIA gene polymorphisms in Streptococcus pneumoniae infection. Immunol Cell Biol 86:268–270CrossRefPubMed
40.
Zurück zum Zitat Kompoti M, Michopoulos A, Michalia M, Clouva-Molyvdas PM, Germenis AE, Speletas M (2015) Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients. Immunobiology 220:414–421CrossRefPubMed Kompoti M, Michopoulos A, Michalia M, Clouva-Molyvdas PM, Germenis AE, Speletas M (2015) Genetic polymorphisms of innate and adaptive immunity as predictors of outcome in critically ill patients. Immunobiology 220:414–421CrossRefPubMed
41.
Zurück zum Zitat Garred P (2008) Mannose-binding lectin genetics: from A to Z. Biochem Soc Trans 36:1461–1466CrossRefPubMed Garred P (2008) Mannose-binding lectin genetics: from A to Z. Biochem Soc Trans 36:1461–1466CrossRefPubMed
42.
Zurück zum Zitat Hansen TK, Thiel S, Dall R, Rosenfalck AM, Trainer P, Flyvbjerg A, Jørgensen JO, Christiansen JS (2001) GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab 86:5383–5388CrossRefPubMed Hansen TK, Thiel S, Dall R, Rosenfalck AM, Trainer P, Flyvbjerg A, Jørgensen JO, Christiansen JS (2001) GH strongly affects serum concentrations of mannan-binding lectin: evidence for a new IGF-I independent immunomodulatory effect of GH. J Clin Endocrinol Metab 86:5383–5388CrossRefPubMed
43.
Zurück zum Zitat Barnes PJ (2013) New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov 12:543–559CrossRefPubMed Barnes PJ (2013) New anti-inflammatory targets for chronic obstructive pulmonary disease. Nat Rev Drug Discov 12:543–559CrossRefPubMed
Metadaten
Titel
Association between TLR2/TLR4 gene polymorphisms and COPD phenotype in a Greek cohort
verfasst von
A. Apostolou
T. Kerenidi
A. Michopoulos
K. I. Gourgoulianis
M. Noutsias
A. E. Germenis
M. Speletas
Publikationsdatum
01.12.2016
Verlag
Springer Medizin
Erschienen in
Herz / Ausgabe 8/2017
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI
https://doi.org/10.1007/s00059-016-4510-9

Weitere Artikel der Ausgabe 8/2017

Herz 8/2017 Zur Ausgabe

Letter to the Editor

Cardiac computed tomography

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.